Skip to content

Single Use Flexible Bronchoscopes in Interventional Pulmonary Procedures

Single Use Versus Standard Flexible Bronchoscopes in Interventional Pulmonary Procedures: an Open Label Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06144398
Enrollment
20
Registered
2023-11-22
Start date
2023-11-27
Completion date
2024-03-29
Last updated
2024-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atelectasis, Hemoptysis, Stridor

Keywords

Bronchoscopy, Single Use Flexible Bronchoscope, Interventional Pulmonology

Brief summary

Single Use Flexible bronchoscopes have gained popularity in recent years and are becoming technologically more advanced. They are widely accepted and used in everyday practice for simple procedures. The aim of this study is to evaluate single use flexible bronchoscopes in more advanced settings, such as interventional pulmonary procedures.

Interventions

The interventional procedure is performed with a single use bronchoscope.

DEVICEStandard Bronchoscope

The interventional procedure is performed with a standard bronchoscope.

Sponsors

Clinical Hospital Centre Zagreb
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* All patients requiring an interventional pulmonary procedure during the study period * Signed informed consent

Exclusion criteria

* Any patient with a contraindication for rigid and/or flexible bronchoscopy * Coagulopathy (PV INR \> 1.3) * Thrombocytopenia (\<50x10\*9 or anemia (Hgb \<80 g/L) * DOAC, LMWH or antiplatelet drug therapy * Thrombophilia, history of pulmonary embolism or deep vein thrombosis * Contraindication for endobronchial application of adrenaline * Uncontrolled coronary artery disease, cerebrovascular disease or arrhythmia * Uncontrolled pulmonary hypertension * Cardiovascular decompensation * Severe hypoxia (PaO2 \<60mmHg, SaO2 \<90% with an FiO2 \>=60%) * Cervical spine instability

Design outcomes

Primary

MeasureTime frameDescription
Overall performancethrough study completion, an average of 12 monthsOverall performance of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)

Secondary

MeasureTime frameDescription
Functionality, handle and interfacethrough study completion, an average of 12 monthsFunctionality, handle and interface of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Suctionthrough study completion, an average of 12 monthsSuction power of the bronchoscope as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Image qualitythrough study completion, an average of 12 monthsImage quality as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Bleeding controlthrough study completion, an average of 12 monthsBleeding control as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)
Compatibilitythrough study completion, an average of 12 monthsCompatibility with other devices (i.e. ballon blockers, forceps, laser, cryprobe) as graded by the operator (on a scale from 1 to 10; 1 worse, 10 best performance)

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026